FAKTOR-OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Market Closed - Deutsche Boerse AG 01:13:17 25/05/2024 am IST | ||
| 1.64 EUR | -2.38% |
|
| Current month | -23.72% | ||
| 1 month | -4.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 1.64 | -2.38% |
| 23/24/23 | 1.68 | +16.67% |
| 22/24/22 | 1.44 | 0.00% |
| 21/24/21 | 1.44 | -5.26% |
| 20/24/20 | 1.52 | -2.56% |
Delayed Quote Deutsche Boerse AG
Last update May 25, 2024 at 01:13 am IST
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SV12L2 |
| ISIN | DE000SV12L22 |
| Date issued | 15/03/2023 |
| Strike | 76.77 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.11 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.02 € |
|---|---|
| Lowest since issue | 1.15 € |
| Spread | 0.01 € |
| Spread % | 0.61% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.98
USD
Average target price
96.16
USD
Spread / Average Target
+9.30%
- Stock Market
- Certificates
- Certificat
